<code id='22A2CC7680'></code><style id='22A2CC7680'></style>
    • <acronym id='22A2CC7680'></acronym>
      <center id='22A2CC7680'><center id='22A2CC7680'><tfoot id='22A2CC7680'></tfoot></center><abbr id='22A2CC7680'><dir id='22A2CC7680'><tfoot id='22A2CC7680'></tfoot><noframes id='22A2CC7680'>

    • <optgroup id='22A2CC7680'><strike id='22A2CC7680'><sup id='22A2CC7680'></sup></strike><code id='22A2CC7680'></code></optgroup>
        1. <b id='22A2CC7680'><label id='22A2CC7680'><select id='22A2CC7680'><dt id='22A2CC7680'><span id='22A2CC7680'></span></dt></select></label></b><u id='22A2CC7680'></u>
          <i id='22A2CC7680'><strike id='22A2CC7680'><tt id='22A2CC7680'><pre id='22A2CC7680'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:79
          Scorecard
          Ryan Pierse/Getty Images

          Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter:

          In December, Vertex Pharmaceuticalsannounced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain. This quarter, the company will read out results from Phase 3 studies of the same pain drug, called VX-548, in people with acute pain following surgery.

          advertisement

          The next big test of Alnylam Pharmaceuticals’pipeline of RNA-interference medicines looms with the outcome of a Phase 3 study called HELIOS-B that is investigating vutrisiran as a treatment for ATTR-CM, a progressive disease that leads to heart failure.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          EMA weighs against approval for Mirati's lung cancer drug
          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

          AdobeItshouldbehard—exceedinglyhard—toobtainthesyntheticDNAneededtorecreatethevirusthatcausedthedead